Fujisaki T, Miyauchi E, Kida G, Miura Y, et al. Durvalumab after concurrent chemoradiotherapy for sensitizing epidermal growth factor receptor-mutant stage III non-small cell lung cancer: A Japanese Real-World data analysis. Lung Cancer 2025;205:108597.
PMID: 40480013